Blinded Reader and Investigator Training Institute (BRITI) Announces Completion of First Accredited Course on Imaging in Cancer Clinical Trials
BRITI and the International Center for Postgraduate Medical Education (ICPME) successfully hosted the first CME course on Imaging in Cancer Clinical Trials on April 16th, 2011 at the Doubletree Hotel in Philadelphia. Speakers included various pharmaceutical industry and academic experts such as Wendy Hayes, DO (Bristol-Myers Squibb), David Raunig, PhD (Pfizer), Sanjay Saini, MD, MBA (Massachusetts General Hospital), James Conklin, MD (Pharma Imaging Group Consortium), and Andrew Buckler, MS (Buckler Biomedical, LLC). Those in attendance ranged from pharmaceutical clinical trial personnel, to imaging core laboratories and independent radiologists.
"We were extremely pleased with the greater than anticipated turnout for our first live CME course, due in large part to the distinguished faculty that we assembled. We're looking forward to future courses in the US, and also in Europe and Asia." said Dr. Rick Patt, Principal of BRITI/Course Co-Director.
The full day course included 7 lectures by industry and academic experts in addition to a panel discussion, where several of the key speakers discussed current topics in clinical trial imaging and answered additional questions from the audience. The course was certified for up to 8.0 AMA PRA Category 1 Credits and 8.0 hours for ARRT Category A continuing education credit.
Dr. James Burke, Vice President of Clinical Research at Jennerex Biotherapeutics said the following, "The BRITI seminar helped me better understand the technical aspects and limitations of clinical trial imaging as well as the critical role played by a central radiology review. The seminar will be invaluable in determining clinical trial design with respect to radiographic endpoints."
The Blinded Reader and Investigator Training Institute (BRITI) offers comprehensive education and training through a broad range of accredited CME courses in the area of medical imaging for pharmaceutical, medical device and biotech clinical trials. For the last few years, BRITI has partnered with ICPME to develop high-quality, well-balanced educational programs of scientific rigor and integrity that are free from commercial bias.